VDRM Stock - ViaDerma, Inc.
Unlock GoAI Insights for VDRM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $600,498 | $540,648 | $514,007 | $11,468 | $10,395 |
| Gross Profit | $600,302 | $540,451 | $511,335 | $10,831 | $9,858 |
| Gross Margin | 100.0% | 100.0% | 99.5% | 94.4% | 94.8% |
| Operating Income | $185,270 | $245,190 | $328,120 | $-70,670 | $-337,760 |
| Net Income | $4,097 | $590,674 | $-994,178 | $-431,673 | $-599,270 |
| Net Margin | 0.7% | 109.3% | -193.4% | -3764.2% | -5765.0% |
| EPS | $0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 |
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.
Visit WebsiteEarnings History & Surprises
VDRMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 1, 2025 | — | — | — | — |
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q2 2025 | Apr 29, 2025 | — | — | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q4 2024 | Dec 16, 2024 | — | $-0.00 | — | — |
Q4 2024 | Oct 3, 2024 | — | — | — | — |
Q2 2024 | Apr 1, 2024 | — | $0.00 | — | — |
Q1 2024 | Mar 21, 2024 | — | — | — | — |
Q4 2023 | Nov 24, 2023 | — | — | — | — |
Q3 2023 | Sep 28, 2023 | — | $-0.00 | — | — |
Q2 2023 | Apr 19, 2023 | — | $-0.00 | — | — |
Q2 2023 | Apr 9, 2023 | — | — | — | — |
Q4 2022 | Dec 30, 2022 | — | $0.00 | — | — |
Q2 2022 | Jun 29, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 30, 2022 | — | $0.00 | — | — |
Q3 2021 | Sep 29, 2021 | — | $0.00 | — | — |
Q2 2021 | Jun 29, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 30, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about VDRM
What is VDRM's current stock price?
What is the analyst price target for VDRM?
What sector is ViaDerma, Inc. in?
What is VDRM's market cap?
Does VDRM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VDRM for comparison